Insights into fetal and neonatal development through analysis of cell-free RNA in body fluids.
The use of cell-free nucleic acids in the circulation of pregnant women for noninvasive prenatal diagnosis is arguably one of the hottest current topics in prenatal medicine. Between 1997 and the present era this field has gone from basic research to clinical application for diagnosis of fetal gender and Rhesus D status. Over the next few years it is likely that noninvasive prenatal diagnosis for Down syndrome will also be possible. Here we summarize current and future clinical applications of analyzing cell-free fetal DNA and RNA in both maternal and neonatal body fluids, including maternal plasma, serum, whole blood, amniotic fluid, and neonatal saliva. We describe methods to evaluate normal and abnormal fetal and neonatal development using gene expression microarrays. We also discuss the ways in which differentially-regulated gene lists can advance knowledge of both fetal and neonatal biology, as well as suggest novel possibilities for fetal and neonatal treatment.
Bianchi
Diana W
DW
Mother Infant Research Institute at Tufts Medical Center, Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, Boston, MA 02111, USA. dbianchi@tuftsmedicalcenter.org
Maron
Jill L
JL
Johnson
Kirby L
KL
D000328:Adult; D000653:Amniotic Fluid; D001826:Body Fluids / Q000737:chemistry*; D002657:Child Development / Q000502:physiology*; D004247:DNA / Q000032:analysis; D005260:Female; D047109:Fetal Development / Q000235:genetics*; D005333:Fetus / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012313:RNA / Q000032:analysis*; D012463:Saliva / Q000737:chemistry
D012313:RNA; D004247:DNA